Skip to content

Medical-device intelligence

QXA: Lateral Flow Immunochromatography Assay For Host Biomarkers Of Respiratory Infection

FDA product code QXA: Lateral Flow Immunochromatography Assay For Host Biomarkers Of Respiratory Infection. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QXA
FDA device name
Lateral Flow Immunochromatography Assay For Host Biomarkers Of Respiratory Infection
Device class
2
Regulation number
866.3230
Medical specialty
Microbiology
Review panel
MI

FDA definition

A device to detect and measure non-microbial analytes to aid in the detection and identification of localized human infections is identified as an in vitro device intended for the detection and qualitative measurement, quantitative measurement, or both of one or more non-microbial analytes in human clinical specimens to aid in the assessment, identification, or both of a localized microbial infection when used in conjunction with clinical signs and symptoms and other clinical and laboratory findings.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

2 clearance records and 0 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Jun 30, 2023 to Mar 24, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202610
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

2 matching records
Device / recordCompany in FDA recordSourceSource date
FebriDx Bacterial/Non-bacterial AssayK260787 · QXALumos Diagnostics, Inc.510(k)Mar 24, 2026FDA decision date
FebriDx Bacterial / Non-bacterial Point of Care AssayK230917 · QXALumos Diagnostics, Inc.510(k)Jun 30, 2023FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗